How COVID-19 impacted UK healthcare

Just one third of people in the UK managed to access the hospital care they needed at the peak of the first wave of the Covid-19 pandemic - according to new research from the University of East Anglia.

A new study published today looks at the extent to which people managed to access NHS healthcare in April 2020, and as lockdown restrictions eased. The researchers found that, despite high levels of unmet need, there was equal access to NHS hospital care for people at different levels of income. And the NHS principle of equal treatment for equal need was upheld.

However, people on higher incomes had better access to GP consultations, prescriptions and medical helplines at the peak of the first wave.

Dr Apostolos Davillas, from UEA's Norwich Medical School, said: "A founding principle and duty of the NHS is to ensure equal access for equal need irrespective of age, location or ability to pay.

"When the Covid-19 pandemic hit, the UK reallocated resources within the health and social care systems to handle coronavirus cases. NHS trusts redesigned their services to release capacity for Covid-19 patients by discharging thousands to free up beds and postponing planned treatments.

"This affected their ability to meet health care need due to other health conditions, illnesses or health emergencies.

"We wanted to find out whether people in the UK were able to use the healthcare services they needed during the first wave of the Covid-19 pandemic, through lockdown and beyond."

The researchers studied data from the UK Household Longitudinal Study (UKHLS), which launched a Covid-19 survey to examine the impact of the coronavirus pandemic.

The study included a sample of 6,598 participants who reported that they had a health care need, and the researchers estimated their healthcare use as the pandemic unfolded between April and July 2020 - to work out the 'unmet need' for healthcare. The study also looked at whether people's long-run income affected access to healthcare.

They found that unmet need was highest for both inpatient and outpatient hospital care shortly after the introduction of the first lockdown on March 23. Levels of unmet need were lower for non-emergency medical helplines and GP consultations, while much lower levels of unmet need were evident for community pharmacist advice, over the counter medications and use of prescription medicines.

Dr Davillas said: "Our study shows that there was a more pronounced impact on secondary care versus primary care services during the peak of the first wave. For example, in late March and April only 33 per cent of those who needed inpatient care managed to use those services, however, 98 per cent of respondents reported that they got their prescription medicines.

"Unmet need became less evident from May through to July 2020. For example, outpatient consultations increased from 47 per cent in April to 63 percent in June, following the easing of lockdown. About 70 per cent of those who needed outpatient care had access to it in July, after the complete easing of the first lockdown on July 4.

"When it comes to the relationship between people's use of healthcare and their income, we found that despite high levels of unmet need, people of all incomes had equal access to the hospital care that was provided. But we found that more well-off people had better access to GP consultations, prescriptions and medical helplines at the peak of the first wave.

"In a publicly funded health care system, pro-rich inequity in health care use may be because people on lower low-incomes are heavily time-constrained, due to harsher employment and living arrangements, and may be less able to seek the health care they need. But we found that this inequality was reduced as the pandemic progressed.

"However, we found persistent pro-rich inequities for services that may be related to people's ability to pay, such as over the counter medications and advice from community pharmacists," he added.

Davillas A, Jones AM.
Unmet health care need and income-Related horizontal equity in use of health care during the COVID-19 pandemic.
Health Econ. 2021. doi: 10.1002/hec.4282

Most Popular Now

Lilly and Lycia Therapeutics enter into strategic …

Eli Lilly and Company (NYSE: LLY) and Lycia Therapeutics, Inc. today announced a multi-year research collaboration and licensing agreement focused on the discovery, devel...

SK bioscience and GSK start Phase 3 trial of adjuv…

SK bioscience (SK) and GlaxoSmithKline plc (GSK) today announced the initiation of a Phase 3 clinical study of SK's COVID-19 vaccine candidate, GBP510, in combination wit...

Blood vessels produce growth factor that promotes …

Blood vessels supply tumors with nutrients and, on the other hand, enable cancer cells to spread throughout the body. The settlement of circulating tumor cells in a dista...

No serious health effects linked to mRNA COVID-19 …

Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 v...

New study examines 'Achilles heel' of cancer tumou…

Researchers at the University of British Columbia's faculty of medicine and BC Cancer Research Institute have uncovered a weakness in a key enzyme that solid tumour cance...

AI algorithm solves structural biology challenges

Determining the 3D shapes of biological molecules is one of the hardest problems in modern biology and medical discovery. Companies and research institutions often spend ...

First-in-human clinical trial for a vaccine to tre…

The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use disorder developed by resear...

A drug costing less than €2 a day helps in the tre…

Metoprolol, a drug widely used to treat cardiovascular disease, is beneficial when administered to COVID-19patients. This is the finding of a study by investigators at th...

Rheumatoid arthritis treated with implanted cells …

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically ...

Sandoz strengthens pipeline by entering into agree…

Sandoz, a Novartis division, today announced that it has entered into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706). B...

Pfizer and BioNTech submit a variation to EMA with…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that they submitted a variation to the European Medicines Agency (EMA) requesting to update the Condition...

One in three Americans had COVID-19 by the end of …

A new study published in the journal Nature estimates that 103 million Americans, or 31 percent of the U.S. population, had been infected with SARS-CoV-2 by the end of 20...